Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Danaher    DHR

Mes dernières consult.
Most popular
News SummaryMost relevantAll newsSector newsTweets

Danaher 1Q Profit Rises 43% On Strong Revenue Growth

share with twitter share with LinkedIn share with facebook
share via e-mail
04/19/2012 | 12:54pm CEST

Danaher Corp.'s (>> Danaher Corporation) first-quarter earnings rose 43% as the diversified manufacturer's revenue growth got a boost from acquisitions.

For the current quarter, Danaher forecast per-share earnings of 76 cents to 81 cents, including anticipated dilution of a penny from its recent deal to acquire X-Rite Inc. (XRIT). Analysts polled by Thomson Reuters expected per-share earnings of 82 cents.

The company narrowed its 2012 per-share earnings estimate to $3.25 to $3.35 from its previous range of $3.20 to $3.35. The new forecast includes 3 cents of anticipated dilution related to X-Rite.

Danaher has remained acquisitive, mostly focusing its efforts on medical technology, testing and measurement and dental equipment. The acquisition of Beckman Coulter last year for $5.78 billion was Danaher's largest deal and gives the company a stronger foothold in the growing diagnostics industry.

More recently Danaher reached a $478 million deal for color-measurement technology company X-Rite in a move Danaher expects will complement its Esko digital design capabilities and further its lead in the product identification industry.

President and Chief Executive H. Lawrence Culp Jr. said the company was encouraged by the quarter-to-quarter business improvement and expects that core growth will accelerate in the second quarter.

Danaher reported a profit of $612.9 million, or 86 cents a share, up from $429.4 million, or 63 cents a share, a year earlier. Earnings from continuing operations were up at 73 cents from 61 cents. Danaher in January had projected earnings of 66 cents to 71 cents.

Revenue increased 31% to $4.32 billion. Excluding acquisitions and currency fluctuations, revenue was up 1.5%

Analysts recently projected $4.33 billion.

Gross margin fell to 51.8% from 53.1%.

Shares closed Wednesday at $54.69 and were inactive premarket.

-By Tess Stynes, Dow Jones Newswires; 212-416-2481; Tess.Stynes@dowjones.com

Stocks mentioned in the article : Danaher Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on DANAHER
08/15 DANAHER : Boost your brand through rapid response
08/14 DANAHER : How These Machinery Stocks are Performing? -- General Electric, Honeyw..
08/02 INSIDER TRADING ACTIVITY DANAHER COR : DHR) – Insider Sold 9,772 shares of..
07/29 DANAHER : Expanding clinical flow cytometry portfolio unveiled by Beckman Coulte..
07/28 Dental Diagnostics & Surgical Equipments Market & Forecast by Products
07/26 EARNINGS REVIEW AND FREE RESEARCH RE : Danaher’s Revenue Grew 6.5%; EPS Ju..
07/26 DANAHER : Earnings Review and Free Research Report: Danaher’s Revenue Grew 6.5%;..
07/25 INSIDER TRADING ACTIVITY DANAHER COR : DHR) – Director Sold 10,578 shares ..
07/25 INSIDER TRADING ACTIVITY DANAHER COR : DHR) – Insider Sold 7,458 shares of..
07/20 DANAHER CORPORATION (NYSE : DHR) reported earnings of $0.99 per share beating Wa..
More news
News from SeekingAlpha
08/14 New positions at Third Point
08/13 Tracking Dan Loeb's Third Point Portfolio - Q2 2017 Update
08/07 Vanguard Brings You Healthy Returns With Less Volatility
08/07 How To Plan For Retirement At 45 With Dividend Stocks
08/03 Lack Of Takeovers Sees Medtech Hiring Staff Again
Financials ($)
Sales 2017 18 052 M
EBIT 2017 3 302 M
Net income 2017 2 301 M
Debt 2017 9 302 M
Yield 2017 0,68%
P/E ratio 2017 24,26
P/E ratio 2018 22,10
EV / Sales 2017 3,65x
EV / Sales 2018 3,35x
Capitalization 56 659 M
Duration : Period :
Danaher Technical Analysis Chart | DHR | US2358511028 | 4-Traders
Technical analysis trends DANAHER
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 15
Average target price 91,5 $
Spread / Average Target 12%
EPS Revisions
Thomas Patrick Joyce President, Chief Executive Officer & Director
Stephen M. Rales Chairman
Daniel L. Comas Chief Financial Officer & Executive Vice President
Alan G. Spoon Independent Director
Donald Jerry Ehrlich Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
DANAHER4.78%56 659
ROYAL PHILIPS11.17%35 080
ILLUMINA51.45%28 370